跳至主要内容
临床试验/NCT01410552
NCT01410552已完成不适用

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

MicroPort CRM139 个研究点 分布在 3 个国家目标入组 1,013 人开始时间: 2011年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,013
试验地点
139
主要终点
Patients With Inappropriate Shock(s)

研究概览

简要总结

ISIS- ICD study has been designed to evaluate the impact of PARAD+ algorithm on inappropriate shocks, in a general population implanted for primary or secondary prevention with a dual or tri chamber device at one year follow-up

详细描述

The primary endpoint is to demonstrate that 95% of patients implanted with PARAD+ algorithm are free from inapproporiate shock compared to 92.5% in general ICD population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient eligible for implantation (according to current accepted guidelines, or scheduled for implant (primo-implant, replacement, upgrade) with a Paradym/Paradym RF (CRT-D or DR-ICD) within the next 30 days, or has already been implanted within the last 30 days
  • Patient in sinus rhythm, or patients with paroxysmal atrial tachyarrhythmia or patients with persistent atrial tachyarrhythmia in whom a cardioversion is planned within three months

排除标准

  • Any contraindication for ICD therapy
  • Atrial lead not implanted
  • Patient with permanent atrial tachyarrhythmia
  • Patients implanted with a ventricular assist device (VAD)

研究组 & 干预措施

ICD or CRT-D with PARAD+

Other

only 1 arm is the study: all patients implanted with ICD or CRT-D with PARAD+ enabled, no comparator

干预措施: PARADYM DR model 8550; PARADYM CRT model 8750; PARADYM RF DR model 9550; PARADYM RF CRT model 9750; PARADYM RF CRT SonR model 9770 (Device)

结局指标

主要结局

Patients With Inappropriate Shock(s)

时间窗: 552 days

Percentage of patients presenting with inappropriate shock(s)

次要结局

  • Shock(s) Appropriately Delivered(552 days)

研究者

发起方
MicroPort CRM
申办方类型
Industry
责任方
Sponsor

研究点 (139)

Loading locations...

相似试验

Inappropriate Shock Reduction wIth PARAD+ Rhythm... | 临床试验